Impact of center volume on chronic graft versus host disease in patients with allogeneic stem cell transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment option for various hematological malignancies and benign conditions, such as aplastic anemia.1,2 However, owing to its specialized and complex nature, allogeneic HSCT practice may vary among transplant centers, including variations in patient selection criteria, transplantation regimens, supportive care practices, and management of post-transplant complications.3 –7 These variations may impact transplant outcomes, making the center experience a crucial factor in improving patient outcomes.

Source: Biology of Blood and Marrow Transplantation - January 10, 2024 Category: Hematology Authors: Yoshimitsu Shimomura, Tetsuhisa Kitamura, Makoto Murata, Keitaro Matsuo, Yuri Ito, Tatsuo Ichinohe, Yoshiko Hashii, Hideki Goto, Koji Kato, Fumihiko Ishimaru, Atsushi Sato, Makoto Onizuka, Atsumi Yanagisawa, Marie Ohbiki, Ken Tabuchi, Yoshiko Atsuta, Taka Source Type: research